Clinical Trial Update: Topiramate vs. Placebo in Preventing Weight Gain in Bipolar Disorder Treated With Olanzapine [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether topiramate can prevent olanzapine-associated weight gain in bipolar disorder; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Topamax (Topiramate)

Snippet

Sponsor: University of Cincinnati | Conditions: Bipolar Disorder, Weight Gain | Phase 4 | Status: COMPLETED | Results posted: 2013-04-04